{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:50:05Z","timestamp":1760061005695,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"am","delay-in-days":162,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-AA020790","U10-AA13566","U24-AA020794"],"award-info":[{"award-number":["U01-AA020790","U10-AA13566","U24-AA020794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01-AA022886"],"award-info":[{"award-number":["R01-AA022886"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["T32","T32HP22240"],"award-info":[{"award-number":["T32","T32HP22240"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jsat.2021.108509","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T02:39:08Z","timestamp":1622255948000},"page":"108509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV"],"prefix":"10.1016","volume":"132","author":[{"given":"Amy J.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica S.","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Skanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Justice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108509_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107670","article-title":"Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs","author":"Adams","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108509_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: Results from a multisite study","author":"Altice","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9738","key":"10.1016\/j.jsat.2021.108509_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2021.108509_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004147.pub4","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl. 2","key":"10.1016\/j.jsat.2021.108509_bb0025","article-title":"The impact of AIDS on adult mortality: Evidence from national and regional statistics","volume":"18","author":"Blacker","year":"2004","journal-title":"Aids"},{"issue":"7","key":"10.1016\/j.jsat.2021.108509_bb0030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2021.108509_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addbeh.2018.03.005","article-title":"The additive effects of depressive symptoms and polysubstance use on HIV risk among gay, bisexual, and other men who have sex with men","volume":"82","author":"Card","year":"2018","journal-title":"Addictive Behaviors"},{"issue":"Suppl. 2","key":"10.1016\/j.jsat.2021.108509_bb0040","article-title":"Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail","volume":"17","author":"Chitsaz","year":"2013","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.jsat.2021.108509_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s10597-018-0284-2","article-title":"Prevalence of HIV viral load suppression among psychiatric inpatients with comorbid substance use disorders","author":"Coviello","year":"2018","journal-title":"Community Mental Health Journal"},{"key":"10.1016\/j.jsat.2021.108509_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000635","article-title":"Executive summary of the focused update of the ASAM national practice guideline for the treatment of opioid use disorder","author":"Crotty","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2021.108509_bb0055","article-title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine\/naloxone","volume":"56","author":"Fiellin","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"8 Suppl. 2","key":"10.1016\/j.jsat.2021.108509_bb0060","article-title":"Development and verification of a \u201cvirtual\u201d cohort using the national VA health information system","volume":"44","author":"Fultz","year":"2006","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2021.108509_bb0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States","author":"Gellad","year":"2017","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2021.108509_bb0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped care for opioid use disorder train the trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities","volume":"41","author":"Gordon","year":"2020","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108509_bb0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2015.01.002","article-title":"Examining the specification validity of the HEDIS quality measures for substance use disorders","volume":"53","author":"Harris","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108509_bb0080","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0049124113503141","article-title":"A note on a stata plugin for estimating group-based trajectory models","volume":"42","author":"Jones","year":"2013","journal-title":"Sociological Methods & Research"},{"issue":"8 Suppl. 2","key":"10.1016\/j.jsat.2021.108509_bb0085","article-title":"Veterans aging cohort study (VACS): Overview and description","volume":"44","author":"Justice","year":"2006","journal-title":"Medical Care"},{"issue":"6","key":"10.1016\/j.jsat.2021.108509_bb0090","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/add.13753","article-title":"Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: A pilot\/feasibility randomized trial","volume":"112","author":"Korthuis","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108509_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2019.05.007","article-title":"Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans","volume":"103","author":"Kraemer","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.jsat.2021.108509_bb0100","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/aje\/kwy092","article-title":"Measurement of current substance use in a cohort of HIV-infected persons in continuity HIV care, 2007\u20132015","volume":"187","author":"Lesko","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"8","key":"10.1016\/j.jsat.2021.108509_bb0105","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/ciw416","article-title":"Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and meta-analysis","volume":"63","author":"Low","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1016\/j.jsat.2021.108509_bb0110","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ntr\/ntr206","article-title":"Validating smoking data from the Veteran\u2019s affairs health factors dataset, an electronic data source","volume":"13","author":"McGinnis","year":"2011","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.jsat.2021.108509_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.014","article-title":"Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment","volume":"204","author":"McGinnis","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2021.108509_bb0120","first-page":"168","article-title":"Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders","volume":"21","author":"Mellins","year":"2009","journal-title":"AIDS Care - Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"issue":"8","key":"10.1016\/j.jsat.2021.108509_bb0125","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2105\/AJPH.2012.301162","article-title":"Substance use among HIV-infected patients engaged in primary care in the United States: Findings from the centers for AIDS Research Network of Integrated Clinical Systems Cohort","volume":"103","author":"Mimiaga","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"9","key":"10.1016\/j.jsat.2021.108509_bb0130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/apc.2007.0243","article-title":"Polysubstance use and HIV\/STD risk behavior among Massachusetts men who have sex with men accessing Department of Public Health mobile van services: Implications for intervention development","volume":"22","author":"Mimiaga","year":"2008","journal-title":"AIDS Patient Care and STDs"},{"issue":"4","key":"10.1016\/j.jsat.2021.108509_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10940-010-9113-7","article-title":"Group-based trajectory modeling (nearly) two decades later","volume":"26","author":"Nagin","year":"2010","journal-title":"Journal of Quantitative Criminology"},{"year":"2018","series-title":"Medications to treat opioid use disorder","author":"National Institute on Drug Abuse","key":"10.1016\/j.jsat.2021.108509_bb0140"},{"issue":"5","key":"10.1016\/j.jsat.2021.108509_bb0145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/QAD.0000000000002125","article-title":"Integration of care for HIV and opioid use disorder","volume":"33","author":"Oldfield","year":"2019","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.jsat.2021.108509_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2021.108509_bb0155","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11920-011-0222-2","article-title":"Barriers to use of pharmacotherapy for addiction disorders and how to overcome them","volume":"13","author":"Oliva","year":"2011","journal-title":"Current Psychiatry Reports"},{"issue":"2","key":"10.1016\/j.jsat.2021.108509_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00952990.2012.741167","article-title":"Trends in opioid agonist therapy in the veterans health administration: Is supply keeping up with demand?","volume":"39","author":"Oliva","year":"2013","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108509_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: The role of methadone maintenance therapy","author":"Palepu","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2021.108509_bb0170","first-page":"348","article-title":"Substance abuse treatment in an urban HIV clinic: Who enrolls and what are the benefits?","volume":"22","author":"Pisu","year":"2010","journal-title":"AIDS Care - Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"issue":"1","key":"10.1016\/j.jsat.2021.108509_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-017-0084-y","article-title":"Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic","volume":"12","author":"Simeone","year":"2017","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.jsat.2021.108509_bb0180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","article-title":"Pharmacological and behavioral treatment of opioid use disorder","volume":"1","author":"Sofuoglu","year":"2019","journal-title":"Psychiatric Research and Clinical Practice"},{"issue":"4","key":"10.1016\/j.jsat.2021.108509_bb0185","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: The impact of buprenorphine treatment","volume":"87","author":"Springer","year":"2010","journal-title":"Journal of Urban Health"},{"issue":"Supplement_4","key":"10.1016\/j.jsat.2021.108509_bb0190","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/508182","article-title":"A trial of integrated buprenorphine\/naloxone and HIV clinical care","volume":"43","author":"Sullivan","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.jsat.2021.108509_bb0195","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","article-title":"An internationally generalizable risk index for mortality after one year of antiretroviral therapy","volume":"27","author":"Tate","year":"2013","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.jsat.2021.108509_bb0200","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jsat.2012.07.011","article-title":"Brief versus extended counseling along with buprenorphine\/naloxone for HIV-infected opioid dependent patients","volume":"43","author":"Tetrault","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108509_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjms.2018.03.002","article-title":"Association of substance use with hospitalization and virologic suppression in a southern academic HIV clinic","author":"Tolson","year":"2018","journal-title":"American Journal of the Medical Sciences"},{"issue":"3","key":"10.1016\/j.jsat.2021.108509_bb0210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08897077.2018.1509251","article-title":"Underutilization of the current clincial capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration","volume":"39","author":"Valenstein-Mah","year":"2018","journal-title":"Journal of Substance Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2021.108509_bb0215","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s10461-018-2210-6","article-title":"Level of alcohol use associated with HIV care continuum targets in a national U.S. sample of persons living with HIV receiving healthcare","volume":"23","author":"Williams","year":"2019","journal-title":"AIDS and Behavior"},{"issue":"1","key":"10.1016\/j.jsat.2021.108509_bb0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10461-020-02950-x","article-title":"Alcohol use and antiretroviral adherence among patients living with HIV: Is change in alcohol use associated with change in adherence?","volume":"25","author":"Williams","year":"2020","journal-title":"AIDS and Behavior"},{"issue":"2","key":"10.1016\/j.jsat.2021.108509_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps","volume":"39","author":"Wyse","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108509_bb0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","article-title":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","volume":"198","author":"Wyse","year":"2019","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054722100235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054722100235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:55:41Z","timestamp":1760039741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054722100235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":46,"alternative-id":["S074054722100235X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108509","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108509"}}